Available to Insight Pharma Reports is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and devling into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD, thier strategies for seeking alternative therapeutic options, and the hardships they have encountered in their reserach and product execution.
Report highlights include:
- Exclusive interviews from four companies (Oraya Therapeutics, VisionCare Ophthalmic Technologies, Omeros, and Kala Pharmaceuticals) providing details of thier products.
- Both invasive and noninvasive procedures are discussed, along with current treatment options and how they relate to rising therapies.
- Demographic survey and analysis of researchers working in ocular disorders including promising therapeutic options, targets of interest, and challenges encountered.
- Over 250 companies featuring clinical trials and pipeline data.